Radiotherapy for recurrent small cell carcinoma of the ovary: A case report and review of the literature

Autor: Donato Callegaro-Filho, Thomas W. Burke, Patricia J. Eifel, Pedro T. Ramirez, Elizabeth E. Euscher, Kathleen M. Schmeler

Publikováno v: Gynecologic Oncology Reports, Vol 11, Iss C, Pp 23-25 (2015)

Externí odkaz: https://doaj.org/article/34c70c24367b4118adfefd5dd35af3c6

Radiotherapy for recurrent small cell carcinoma of the ovary: A case report and review of the literature

Autor: Donato Callegaro-Filho, Elizabeth E. Euscher, Patricia J. Eifel, Thomas W. Burke, Pedro T. Ramirez, Kathleen M. Schmeler

Publikováno v: Gynecologic Oncology Reports
Gynecologic Oncology Reports, Vol 11, Iss C, Pp 23-25 (2015)

Highlights • Small cell carcinoma of the ovary is a rare and aggressive malignant tumor. • No effective treatment for recurrent disease has yet been described. • Patients with recurrent disease may respond to salvage surgery, chemotherapy, radi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffe3b658e56001631c11aeb1b7b122cb

Pathology of sentinel lymph nodes: historical perspective and current applications in gynecologic cancer.

Autor: Euscher E; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA EDEusche@mdanderson.org.

Publikováno v: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2020 Mar; Vol. 30 (3), pp. 394-401. Date of Electronic Publication: 2020 Feb 19.

Pathologic Prognostic Factors in Endometrial Carcinoma (Other Than Tumor Type and Grade).

Autor: Singh N; Department of Cellular Pathology, Barts Health NHS Trust, London (N.S.) Department of Cellular Pathology, Birmingham Women's NHS Trust, Birmingham (L.H.) Department of Pathology, Belfast Health and Social Care Trust, Belfast (W.G.M.), UK Division of Anatomic Pathology, Hershey Medical Center, Pennsylvania State University, Hershey, Pennsylvania (R.Z.) Department of Pathology, Mexico City Hospital of Oncology, Mexico City, Mexico (I.A.-C.) Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Alberta, Canada (M.A.D.) Department of Pathology, Wayne State University, Detroit, Michigan (R.A.-F.) Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas (E.E., A.M.) Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School (J.L.H.) Department of Pathology, Brigham and Women's Hospital, Harvard Medical School (M.N.) Department of Pathology, Massachusetts General Hospital, Harvard Medical School (E.O.), Boston, Massachusetts Division of Gynecologic, Breast & Perinatal Pathology, University Hospital Leipzig, Leipzig (L.-C.H.) Institute of Pathology, University Hospital of Tübingen, Tübingen (A.S.), Germany Department of Anatomical Pathology, University of Maryland, College Park, Maryland (O.I.) Pathological Oncology Group and Pathology Department, University Hospital of Arnau de Vilanova, Lleida (X.M.-G.) Department of Pathology, Hospital Clinic of Barcelona, ISGlobal, Barcelona Center for International Health Research, University of Barcelona, Barcelona (J.O.), Spain Department of Diagnostic Pathology, Kumamoto University Hospital, Kumamoto, Japan (Y.M.) Department of Pathology, Yale University School of Medicine, New Haven, Connecticut (V.P.) Department of Pathology, Women and Infants Hospital/Warren Alpert Medical School of Brown University, Providence, Rhode Island (M.R.Q.) Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, Arkansas (C.M.Q.) Department of Pathology, University of California, San Francisco, San Francisco, California (C.Z.)., Hirschowitz L, Zaino R, Alvarado-Cabrero I, Duggan MA, Ali-Fehmi R, Euscher E, Hecht JL, Horn LC, Ioffe O, Matias-Guiu X, McCluggage WG, Mikami Y, Ordi J, Parkash V, Quddus MR, Quick CM, Staebler A, Zaloudek C, Nucci M, Malpica A, Oliva E

Publikováno v: International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists [Int J Gynecol Pathol] 2019 Jan; Vol. 38 Suppl 1, pp. S93-S113.

A prospective validation study of sentinel lymph node mapping for high-risk endometrial cancer.

Autor: Soliman PT; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas, M.D. Anderson Cancer Center, Houston, TX, United States. Electronic address: psoliman@mdanderson.org., Westin SN; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas, M.D. Anderson Cancer Center, Houston, TX, United States., Dioun S; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas, M.D. Anderson Cancer Center, Houston, TX, United States., Sun CC; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas, M.D. Anderson Cancer Center, Houston, TX, United States., Euscher E; Department of Pathology, University of Texas, M.D. Anderson Cancer Center, Houston, TX, United States., Munsell MF; Division of Biostatistics, University of Texas, M.D. Anderson Cancer Center, Houston, TX, United States., Fleming ND; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas, M.D. Anderson Cancer Center, Houston, TX, United States., Levenback C; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas, M.D. Anderson Cancer Center, Houston, TX, United States., Frumovitz M; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas, M.D. Anderson Cancer Center, Houston, TX, United States., Ramirez PT; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas, M.D. Anderson Cancer Center, Houston, TX, United States., Lu KH; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas, M.D. Anderson Cancer Center, Houston, TX, United States.

Publikováno v: Gynecologic oncology [Gynecol Oncol] 2017 Aug; Vol. 146 (2), pp. 234-239. Date of Electronic Publication: 2017 May 18.